Localization of the domains involved in ligand binding and activation of the glucose-dependent insulinotropic polypeptide receptor

Endocrinology
R W GellingC H McIntosh

Abstract

The receptors for the two structurally related insulinotropic hormones Glucose-dependent Insulinotropic Polypeptide (GIP) and Glucagon-Like Peptide-1 (GLP-1) share approximately 40% sequence identity and demonstrate complete specificity for their endogenous ligands, while utilizing similar second messenger pathways. In the current study chimeric GIP-GLP-1 receptors were prepared, and the effect of domain-exchange on ligand binding and adenylyl cyclase activation examined. A chimera (CH-2) consisting of the first 132 amino acids of the external N-terminal (NT) domain bound 125I-GIP with high affinity (27.77 +/- 11.85 nM). However, for receptor coupling to cAMP production it was necessary to extend the NT into the first transmembrane (TM-1) region (CH-3: IC50 = 9.04 +/- 1.07 nM; EC50 = 17.1 +/- 3.5 nM). A chimera which included part of TM-3 (CH-4) demonstrated binding and signalling (IC50 = 8.33 +/- 0.14 nM; EC50 = 467.5 +/- 173.6 pM) similar to the wild type receptor (IC50 = 1.33 +/- 0.19 nM; EC50 = 497.9 +/- 211.7 pM). Surprisingly constructs CH-2 and CH-3, while devoid of detectable 125I-GLP-1 binding, were capable of eliciting GLP-1-specific cAMP production (EC50s CH-2 = 81.4 +/- 19.6 nM; CH-3 = 5.99 +/- 0.68 nM) suggesting t...Continue Reading

Citations

Aug 24, 2007·Proceedings of the National Academy of Sciences of the United States of America·Christoph ParthierMilton T Stubbs
Dec 17, 2008·Pharmacological Reviews·Wook Kim, Josephine M Egan
Jul 30, 2005·Neuromolecular Medicine·Bronwen MartinStuart Maudsley
Jun 5, 2012·Pharmacology & Therapeutics·Young Min ChoTimothy J Kieffer
May 19, 2009·Trends in Biochemical Sciences·Christoph ParthierMilton T Stubbs
Jul 2, 2011·British Journal of Pharmacology·Sebastian G B FurnessPatrick M Sexton
May 18, 2016·Journal of Diabetes Investigation·Raymond A Pederson, Christopher Hs McIntosh
Aug 11, 2004·Life Sciences·Simon A HinkeChristopher H S McIntosh
Dec 22, 1999·Endocrine Reviews·T J Kieffer, J F Habener
Jan 24, 1998·Molecular Endocrinology·S A HjorthT W Schwartz
May 2, 2003·American Journal of Physiology. Endocrinology and Metabolism·Ke-Hong DingCarlos M Isales
Nov 12, 2003·The Journal of Biological Chemistry·Simon A HinkeChristopher H S McIntosh

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Biology of GLP-1

Glucagon-like peptide 1 (GLP-1) plays a role in glucose metabolism, energy homeostasis, and inflammation suppression. GLP-1 receptor signaling has been shown to impact cardiovascular function. This feed focuses on the role of GLP-1 and GLP-1 receptor agonists on cardiovascular biology.